Weekly Recap: Cash runway through 2028 and OCU400 Phase 3/BLA in 2027
Ocugen Inc (NASDAQ:OCGN) closed the quarter with $100.1M in cash and says recent financing extends its runway through 2028 as shares trade just above $1; the company is advancing OCU400 toward topline Phase 3 results in Q1 2027 and a planned U.S. BLA submission in Q2 2027 while holding orphan and A…